Note 2 - BASIS OF REPORTING AND GOING CONCERN	9 Months Ended
Feb. 28, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Note 2 - BASIS OF REPORTING AND GOING CONCERN	Note 2 - BASIS OF REPORTING AND GOING CONCERN The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business. The Company has incurred losses from inception of approximately $22,600,000, has a working capital deficiency of approximately $1,570,000 and a net capital deficiency of approximately $1,317,000, which, among other factors, raises substantial doubt about the Company's ability to continue as a going concern. As of February 28, 2022, the Company did not have sufficient cash on hand to fund operations for the next 12 months. The ability of the Company to continue as a going concern is dependent upon management's plans to raise additional capital from the sale of stock and receive additional loans from third parties and related parties. The acquisition of the CareClix Group is expected to provide sufficient revenues to support the continued operations of the Company. As of February 28, 2022, the CareClix subsidiaries had advanced at total of $92,600 to the Company to support its operations. The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.

Note 2 - BASIS OF REPORTING AND GOING CONCERN

9 Months Ended

Feb. 28, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Note 2 - BASIS OF REPORTING AND GOING CONCERN

The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates the recoverability of assets and the satisfaction of liabilities in the normal course of business.

The Company has incurred losses from inception of approximately $22,600,000, has a working capital deficiency of approximately $1,570,000 and a net capital deficiency of approximately $1,317,000, which, among other factors, raises substantial doubt about the Company's ability to continue as a going concern. As of February 28, 2022, the Company did not have sufficient cash on hand to fund operations for the next 12 months. The ability of the Company to continue as a going concern is dependent upon management's plans to raise additional capital from the sale of stock and receive additional loans from third parties and related parties. The acquisition of the CareClix Group is expected to provide sufficient revenues to support the continued operations of the Company. As of February 28, 2022, the CareClix subsidiaries had advanced at total of $92,600 to the Company to support its operations. The accompanying financial statements do not include any adjustments that might be required should the Company be unable to continue as a going concern.

Life On Earth, Inc. 10-Q